Cervical lesion drug trial halted early
Disease control
Terminated
This study tested an experimental vaginal insert (ABI-2280) in women with cervical precancerous lesions. The goal was to see if it was safe and could help clear abnormal cells. The trial was stopped early, and results are not yet available.
Phase: PHASE1, PHASE2 • Sponsor: Antiva Biosciences • Aim: Disease control
Last updated May 15, 2026 11:57 UTC